| mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-06 |
| mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |
| mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
| mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
| mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
| mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.008 |
| mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.008 |
| mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.009 |
| mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |